Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes

Overview[ - collapse ][ - ]

Purpose to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Technosphere Insulin
Drug: Metformin & Secretagogues
Drug: Technosphere Insulin & Metformin
PhasePhase 3
SponsorMannkind Corporation
Responsible PartyMannkind Corporation
ClinicalTrials.gov IdentifierNCT00332488
First ReceivedMay 31, 2006
Last UpdatedOctober 1, 2009
Last verifiedOctober 2009

Tracking Information[ + expand ][ + ]

First Received DateMay 31, 2006
Last Updated DateOctober 1, 2009
Start DateDecember 2004
Estimated Primary Completion DateNot Provided
Current Primary Outcome MeasuresChange from baseline to Week 12 in glycated hemoglobin [Time Frame: 12 weeks] [Designated as safety issue: No]
Current Secondary Outcome MeasuresChange in HbA1c from baseline [Time Frame: 24 weeks] [Designated as safety issue: No]

Descriptive Information[ + expand ][ + ]

Brief TitleEfficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes
Official TitleA Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents (Metformin and a Secretagogue) in Subjects With Type 2 Diabetes Mellitus Sub-optimally Controlled on Combination Metformin and a Secretagogue.
Brief Summary
to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin
versus combination metformin and a secretagogue
Detailed DescriptionNot Provided
Study TypeInterventional
Study PhasePhase 3
Study DesignAllocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
ConditionDiabetes Mellitus, Type 2
InterventionDrug: Technosphere Insulin
Inhalation, 15U/30U, prandial
Drug: Metformin & Secretagogues
Metformin tablets,Secretagogues supplied as any of the currently marketed brands and formulations.
Drug: Technosphere Insulin & Metformin
Technosphere Insulin Inhalation Powder 15U/30U, Metformin tablets
Study Arm (s)
  • Experimental: 1
    Technosphere Insulin
  • Active Comparator: 2
    Metformin & Secretagogues
  • Experimental: 3
    Technosphere & Metformin

Recruitment Information[ + expand ][ + ]

Recruitment StatusCompleted
Estimated Enrollment547
Estimated Completion DateNot Provided
Estimated Primary Completion DateMarch 2008
Eligibility Criteria
Inclusion Criteria:

- Non-smokers with clinical diagnosis of Type 2 diabetes mellitus for >or= to 6 months

- Stable regimen of metformin for > or = to 1000mg/day 9or maximum tolerated dose) and
a secretagogue < or = 1/2 the maximum manufacturer-recommended daily dose without any
dose adjustments within the preceding 6 wks.

- Fixed dose combination products of metformin and sulfonylurea are acceptable as long
as each individual dose meets inclusion criteria

- HbA1c >or= to 7.5% and < or= to 11.0%

- BMI < or = to 40kg/m2.

- FEV1> or = to 70%, Total Lung capacity and > or =80% DLco > or= to 70%

Exclusion Criteria:

- Treatment with any type of anti-diabetic therapy, other than metformin &
secretagogues within the preceding 12 weeks

- Serum creatinine > 1.4mg/dL in female subjects and >1.5mg/dL in male subjects

- History of chronic obstructive pulmonary disease, clinically proven asthma and/or any
other clinically important pulmonary function testing and/or radiologic findings

- Evidence of serious complications of diabetes (e.g. autonomic neuropathy)
GenderBoth
Ages18 Years
Accepts Healthy VolunteersNo
ContactsNot Provided
Location CountriesUnited States, Argentina, Brazil, Canada, Chile, Czech Republic, Mexico, Poland, Russian Federation, Spain, Ukraine

Administrative Information[ + expand ][ + ]

NCT Number NCT00332488
Other Study ID NumbersMKC-TI-103
Has Data Monitoring CommitteeNot Provided
Information Provided ByMannkind Corporation
Study SponsorMannkind Corporation
CollaboratorsNot Provided
Investigators Study Director: Anders Boss Mannkind Corporation
Verification DateOctober 2009

Locations[ + expand ][ + ]

Radiant Research-Birmingham
Birmingham, Alabama, United States, 35209
Parkway Medical Center
Birmingham, Alabama, United States, 35215
Redpoint Research
Phoenix, Arizona, United States, 85029
Arizona Center for Clinical Research
Phoenix, Arizona, United States, 85032
International Clinical Research Network
Chula Vista, California, United States, 91911
Jennifer Hone MD
Denver, Colorado, United States, 80220
Creekside Endocrine Associates
Denver, Colorado, United States, 80209
National Jewish Medical & Research Center
Denver, Colorado, United States, 80206
Chase Medical Research, LLC
Waterbury, Connecticut, United States, 06708
Center for Diabetes & Endocrine Care
Hollywood, Florida, United States, 33021
International Research Associates LLC
Miami, Florida, United States, 33156
John H Stoger Jr Hospital of Cook County
Chicago, Illinois, United States, 60612
Cedar-Crosse Research Center
Chicago, Illinois, United States, 60607
Clintell Inc
Skokie, Illinois, United States, 60076
James A Dicke MDPA
Towson, Maryland, United States, 21204
East Coast Clinical Research Inc
Haverhill, Massachusetts, United States, 01830
Wayne State University
Detroit, Michigan, United States, 48201
Michigan Institute of Medicine
Livonia, Michigan, United States, 48152
Raidant Research-St Louis
St Louis, Missouri, United States, 63141
Clayton Medical Research
St Louis, Missouri, United States, 63117
Washington University School of Medicine
St. Louis, Missouri, United States, 63110
Creighton Diabetes Center
Omaha, Nebraska, United States, 68131
Lovelace Scientific Resources (Albuquerque)
Albuquerque, New Mexico, United States, 87108
Winthrop University Hospital
Mineola, New York, United States, 11501
North Shore Diabetes and Endocrine Associates
New Hyde Park, New York, United States, 11042
Metrolina Internal Medicine
Charlotte, North Carolina, United States, 28204
Sensenbrenner Primary Care
Charlotte, North Carolina, United States, 28277
Charlotte Clinical Research Inc
Charlotte, North Carolina, United States, 28211
Duke Medical Center
Durham, North Carolina, United States, 27710
Providence Health Partners - Center of Clinical Research
Dayton, Ohio, United States, 45439
Dayton Clinical Research
Dayton, Ohio, United States, 45406
Radiant Research
Portland, Oregon, United States, 97239
Upstate Pharmaceutical Research
Greenville, South Carolina, United States, 29615
Collierville Medical Specialists
Collierville, Tennessee, United States, 38017
Memphis Internal Medicine (Kathawala)
Memphis, Tennessee, United States, 38119
GoodLife Medical Center PLLC
Memphis, Tennessee, United States, 38120
Baylor Endocrine Center
Dallas, Texas, United States, 75246
Covenant Clinic Research
San Antonio, Texas, United States, 78229
SAM Clinical Research Center
San Antonio, Texas, United States, 78229
Quality Assurance Research Center Inc
San Antonio, Texas, United States, 78205
Clinical Trials of Texas Inc
San Antonio, Texas, United States, 78229
Diabetes & Glandular Disease Research Assoc PA
San Antonio, Texas, United States, 78229
Cedar Research
Tacoma, Washington, United States, 98405
Hospital Interzonal de Agudos Pedro Fiorito
Avellaneda, Buenos Aires, Argentina, B1870ARG
Centro Endocrinologic Tiempo
Buenos Aires, Argentina, C1117ABH
CIMeL
Buenos Aires, Argentina
Hospital Italiano de Buenos Aires
Buenos Aires, Argentina, C1181ACH
Cons Asoc de Endocrinologia
Buenos Aires, Argentina, C1425AGC
Hospital Sao Lucas da PUCRS
Porto Alegre, Rio Grande do Sul, Brazil, 90610-000
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903
Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda
Rio de Janeiro, Brazil, 22271-100
Hospital Guilherme Alvaro
Santos, Brazil, 11045-904
Instituto de Pesquisa Clinica e Medicina Avancada
Sao Paulo, Brazil, 05437-010
Hospital do Rim e Hipertensao
Sao Paulo, Brazil, 04025-011
CPClin-Centro de Pesquisas Clinicas
Sao Paulo, Brazil, 01244-030
UNIFRSP
Sao Paulo, Brazil, 04020-050
Quest Clinical Trials
Markham, Ontario, Canada, L6B 1A1
Lifestyle Metabolism Center
Oakville, Ontario, Canada, L6H 3P1
Lifestyle Metabolism Center
Thornhill, Ontario, Canada, L4J 8L7
Lifestyle Metabolism Center
Toronto, Ontario, Canada, M4R 2G4
Trial Management Group Inc (Henein
Toronto, Ontario, Canada, M4T 1N5
Unimedico Management
Richmond Hill, Canada, L4C 9M7
Hospital Padre Alberto Hurtado
Santiago, Region Metropolitana, Chile
Hospital del Salvador
Santiago, Chile
Instituto de Informacion de Tramiento y Educacion en Salud
Santiago, Chile
Hospital Clinico Pontificia Universidad Catolica de Chile
Santiago, Chile
Diabetologicka a interni ambulance
707 02 Ostrava-Kuncice, CZE, Czech Republic, 70702
Institute for Clinical and Exp Medicine
Prague 4, CZE, Czech Republic, 140 21
University Hospital Na Bulovce
Prague 8, CZE, Czech Republic, 180 81
Diabetologicka ambulance (Chmura)
Ostrava, Czech Republic, 70200
Interní a diabetologická Outpatient
Ostrava, Czech Republic, 70900
Endokrinologicky ustav
Praha 1, Czech Republic, 11694
II interni klinika FN Kralovske Vinohrady
Praha 10, Czech Republic, 10034
3rd Medical Department General Faculty Hospital
Praha 2, Czech Republic, 12801
Instituto Mexicano de Investigacion
Mexico City, Durango, Mexico, 06700
Hospital Universitario Dr Jose E Gonzalez
Monterrey, Nuevo Leon, Mexico, 64460
Hospital Santa Engracia-CIMA
Garza Garcia, Mexico, 66260
Centro de Estudios en Diabetes
Mexico City, Mexico, 01120
Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio
Mexico City, Mexico, 06726
OCA-MIRC
Monterrey, Mexico, 64020
Klinika Endocrinologii Diabetologii I
Bialystock, POL, Poland, 15-276
NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny
Bialystok, POL, Poland, 15-435
Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego
Krakow, POL, Poland, 31 501
Instytut Centrum Zdrowia (009) Matki Polki
Lodz, POL, Poland, 93-338
Spzital Kolejowy imm Wlodzimierza Roeflera
Pruszkow, POL, Poland, 05-800
Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego
Lodz, Poland, 90-153
Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED
Warsaw, Poland, 03 580
Centrum Leczenia Chorob cywilizacyjnych
Warszawa, Poland, 02 777
NHI Kemerovo Regional Clinical Hospital
Kemerovo, RUS, Russian Federation, 650061
NI Endrocrinological Research Centre of RAMS In patient replacing technologies department
Moscow, RUS, Russian Federation, 115478
NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky
Moscow, RUS, Russian Federation, 129110
NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense
Moscow, RUS, Russian Federation, 105229
NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70
Moscow, RUS, Russian Federation, 111399
NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital
Smolensk, RUS, Russian Federation, 214018
Central Medical Sanitary Unit #122
St Petersburg, RUS, Russian Federation, 194291
St Petersburg NHI City Polytclinic #77 City Diabetological Center #4
St Petersburg, RUS, Russian Federation, 193012
TUV Medico-Military Academy
St Petersburg, RUS, Russian Federation, 198013
St Petersburg NHI Municipal Multi-Speciality Hospital # 2
St. Petersburg, RUS, Russian Federation, 194354
NHI Yaroslavl Regional Clinical Hospital
Yaroslavl, RUS, Russian Federation, 150062
MHI Clinical Hospital for Emergency Care na NV Soloviev
Yaroslavl, RUS, Russian Federation, 150003
NI Central Clinical Hospital of RAS
Moscow, Russian Federation, 117 593
Complejo Hospitalario Nuestra Senora de Valme
Sevilla, Andalucia, Spain, 41014
Hospital Clinic I Provincial
Barcelona, Spain, 08036
Hospital Ramon y Cajal
Madrid, Spain, 28034
Hospital Universitario de la Princessa
Madrid, Spain, 28006
Corporacion Sanitaria Parc Tauli Unidad de Endocrinologia
Sabadell, Spain, 08208
Bukovinian State Medical University Dept of Clinical Immun
Chernivtsy, UKR, Ukraine, 58022
Dniepropetrovsh State Medical Academy
Dniepropetrovsk, UKR, Ukraine, 49023
Railway Clinical Hospital on Donetsk Station
Donetsk, UKR, Ukraine, 83114
Donetsk State Medical University
Donetsk, UKR, Ukraine, 83003
Donetsk State Medical University (Chair of Immun Allergogoly & Endocrin)
Donetsk, UKR, Ukraine, 83099
Institute of Endocrinology and Metabolism
Kiev, UKR, Ukraine, 04114
Chair Family Med of National Med University
Kiev, UKR, Ukraine, 04050
Ukr Scientifically Practical Centre of Endocrine Surgery
Kiev, UKR, Ukraine, 2175
Odessa Reg. Clinical Hosp Outpatient Department
Odessa, UKR, Ukraine, 65025
Odessa State Medical University Dept of Gen Practice and Med Rehab
Odessa, UKR, Ukraine, 65009
Odessa State Med Dept of Family Med and Gen Practice
Odessa, UKR, Ukraine, 65039
Vinnitsa State Medical University
Vinnitsa, UKR, Ukraine, 21010
Outpatient Clinic of Family Physician "Rusanovka"
Kiev, Ukraine, 02147
Public Institution City Policlinic #20 Odessa
Odessa, Ukraine, 65114